Core Viewpoint - Zhenghai Bio (300653) announced on October 27 that it will continue its strategy of stable operations and actively returning profits to investors, maintaining annual performance dividends since its listing [1] Group 1 - The company emphasizes its commitment to investor returns based on overall performance [1] - Future plans include developing specific employee incentive schemes in accordance with relevant regulations [1] - The company encourages stakeholders to pay attention to upcoming announcements regarding these incentive plans [1]